Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
出版年份 2017 全文链接
标题
Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
作者
关键词
HPV-16, Immune serum, Enzyme-linked immunoassays, Antibodies, Human papillomavirus infection, Antigens, Vaccines, Vaccination and immunization
出版物
PLoS One
Volume 12, Issue 1, Pages e0169533
出版商
Public Library of Science (PLoS)
发表日期
2017-01-10
DOI
10.1371/journal.pone.0169533
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 426 cGMP production of a chimeric virus-like particle vaccine (RG1-VLP) for prevention of HPV-associated cancers
- (2016) R. Kirnbauer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles
- (2016) Mathieu Boxus et al. JOURNAL OF VIROLOGY
- Human papillomavirus detected in viral warts of renal transplant recipients
- (2016) F. Martelli-Marzagão et al. Transplant Infectious Disease
- A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects
- (2016) Erin M. Scherer et al. EBioMedicine
- Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2
- (2015) Ebenezer Tumban et al. VACCINE
- Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach
- (2015) Wai-Hong Wu et al. Virology Journal
- Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia
- (2015) Nagayasu Egawa et al. Viruses-Basel
- HPV Carcinomas in Immunocompromised Patients
- (2015) Nicole Reusser et al. Journal of Clinical Medicine
- A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types
- (2015) Bettina Huber et al. PLoS One
- Betapapillomaviruses in the anal canal of HIV positive and HIV negative men who have sex with men
- (2014) Boštjan Mlakar et al. JOURNAL OF CLINICAL VIROLOGY
- HumanBeta-papillomavirusinfection and keratinocyte carcinomas
- (2014) Koen D Quint et al. JOURNAL OF PATHOLOGY
- A Cryo-Electron Microscopy Study Identifies the Complete H16.V5 Epitope and Reveals Global Conformational Changes Initiated by Binding of the Neutralizing Antibody Fragment
- (2014) Hyunwook Lee et al. JOURNAL OF VIROLOGY
- Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
- (2014) Kihyuck Kwak et al. PLoS One
- Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes
- (2014) Kirill Kalnin et al. VACCINE
- Comparison of the immunogenicity of Cervarix®and Gardasil®human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults
- (2014) Lars Toft et al. Human Vaccines & Immunotherapeutics
- Protective Vaccination against Papillomavirus-Induced Skin Tumors under Immunocompetent and Immunosuppressive Conditions: A Preclinical Study Using a Natural Outbred Animal Model
- (2014) Sabrina E. Vinzón et al. PLoS Pathogens
- Immunogenicity of Quadrivalent Human Papillomavirus Vaccine in Organ Transplant Recipients
- (2013) D. Kumar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
- (2013) Christina Schellenbacher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Optimization of Multimeric Human Papillomavirus L2 Vaccines
- (2013) Subhashini Jagu et al. PLoS One
- Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study
- (2013) Lynette Denny et al. VACCINE
- A universal virus-like particle-based vaccine for human papillomavirus: Longevity of protection and role of endogenous and exogenous adjuvants
- (2013) Ebenezer Tumban et al. VACCINE
- A Human Papillomavirus (HPV)In VitroNeutralization Assay That Recapitulates theIn VitroProcess of Infection Provides a Sensitive Measure of HPV L2 Infection-Inhibiting Antibodies
- (2012) Patricia M. Day et al. Clinical and Vaccine Immunology
- Intranasal Vaccination with AAV5 and 9 Vectors Against Human Papillomavirus Type 16 in Rhesus Macaques
- (2012) Karen Nieto et al. HUMAN GENE THERAPY
- Warts and all: Human papillomavirus in primary immunodeficiencies
- (2012) Jennifer W. Leiding et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice
- (2012) Sun-Woo Yoon et al. VACCINE
- The Oral Cavity Contains Abundant Known and Novel Human Papillomaviruses From the Betapapillomavirus and Gammapapillomavirus Genera
- (2011) Danielle Bottalico et al. JOURNAL OF INFECTIOUS DISEASES
- A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
- (2011) Ebenezer Tumban et al. PLoS One
- The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic
- (2011) Shahan Mamoor et al. VIROLOGY
- Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine
- (2010) Michel Deschuyteneer et al. Human vaccines & immunotherapeutics
- Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine in HIV-Infected Children 7 to 12 Years Old
- (2010) Myron J Levin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
- (2010) Subhashini Jagu et al. VACCINE
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
- (2010) Hans-Ulrich Bernard et al. VIROLOGY
- Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland
- (2009) L.J. Mackintosh et al. BRITISH JOURNAL OF DERMATOLOGY
- Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
- (2009) Subhashini Jagu et al. JNCI-Journal of the National Cancer Institute
- Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
- (2009) C. Schellenbacher et al. JOURNAL OF VIROLOGY
- The EVER Proteins as a Natural Barrier against Papillomaviruses: a New Insight into the Pathogenesis of Human Papillomavirus Infections
- (2009) M. Lazarczyk et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20–38) peptide displayed on bacterial thioredoxin
- (2009) Ivonne Rubio et al. VACCINE
- Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs
- (2009) Tilo Senger et al. VACCINE
- Dermatologic manifestations of HPV in HIV-infected individuals
- (2009) Rachel H. Gormley et al. Current HIV/AIDS Reports
- Serological relationship between cutaneous human papillomavirus types 5, 8 and 92
- (2008) A. Handisurya et al. JOURNAL OF GENERAL VIROLOGY
- Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2
- (2008) H. H. Alphs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started